v3.26.1
Revenue - Additional Information (Details) - USD ($)
1 Months Ended
Feb. 29, 2024
Jun. 30, 2026
Dec. 31, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Revenue Recognition            
Billed contracts receivable   $ 14,700,000 $ 95,600,000      
Unbilled contracts receivable   4,100,000 10,800,000      
Allowance for credit losses   0   $ 0    
Amount of transaction price not yet satisfied   600,000,000        
Deferred revenue   443,332,000 498,996,000 $ 513,026,000   $ 1,121,886,000
Claim related to performance obligation         $ 23,000,000.0  
Other current liabilities   135,527,000 137,778,000      
Other non-current liabilities   165,744,000 239,068,000      
Current deferred revenue   86,577,000 140,053,000      
Noncurrent deferred revenue   356,755,000 $ 358,943,000      
Australia Revenue Agency Member            
Revenue Recognition            
Deferred revenue refund   92,500,000        
Noncurrent deferred revenue   85,400,000        
Settlement Agreement            
Revenue Recognition            
Litigation settlement, expense $ 400,000,000          
Grants receivable 225,000,000 225,000,000.0        
Litigation settlement, amount awarded to other party 75,000,000          
Other current liabilities   80,000,000.0        
Other non-current liabilities   145,000,000.0        
Gavi Advance Purchase Agreement- COVAX Facility            
Revenue Recognition            
Collaborative agreement, upfront payment amount 700,000,000          
Australian APA            
Revenue Recognition            
Advanced payment paid   31,000,000        
Current deferred revenue   $ 48,400,000        
Gavi Settlement Agreement            
Revenue Recognition            
Litigation settlement, expense $ 80,000,000